Page 25 - Read Online
P. 25

Page 4 of 5                                           Sugawara et al. Hepatoma Res 2018;4:33  I  http://dx.doi.org/10.20517/2394-5079.2018.69

               HCC and cirrhosis. The indication of transplantation in patients with HCC still continues to be under
               debate in Japan.



               DECLARATIONS
               Authors’ contributions
               Designed the study: Yamamoto H, Hibi T
               Wrote the draft of the manuscript: Sugawara Y


               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               None.


               Conflicts of interest
               All authors declare that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2018.



               REFERENCES
               1.   Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma.
                   Gastroenterology 2016;150:835-53.
               2.   El-Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology
                   2014;60:1767-75.
               3.   Penn I, Starzl TE. Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation 1972;14:407-17.
               4.   Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver
                   transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9.
               5.   Mancuso A, Perricone G. Hepatocellular carcinoma and liver transplantation: state of the art. J Clin Transl Hepatol 2014;2:176-81.
               6.   de Villa V, Lo CM. Liver transplantation for hepatocellular carcinoma in Asia. Oncologist 2007;12:1321-31.
               7.   Hwang S, Moon DB, Lee SG. Liver transplantation and conventional surgery for advanced hepatocellular carcinoma. Transpl Int
                   2010;23:723-7.
               8.   Chan SC. Liver transplantation for hepatocellular carcinoma. Liver Cancer 2013;2:338-44.
               9.   Umeshita K, Inomata Y, Furukawa H, Kasahara M, Kawasaki S, Kobayashi E, Kokudo N, Sakisaka S, Shimada M, Tanaka E, Uemoto S;
                   Japanese Liver Transplantation Society. Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society. Hepatol
                   Res 2016;46:1171-1186.
               10.  Tamura S, Sugawara Y, Kokudo N. Living donor liver transplantation for hepatocellular carcinoma: the Japanese experience. Oncology
                   2011;81 Suppl 1:111-5.
               11.  Todo S, Furukawa H, Tada M. Extending indication: role of living donor liver transplantation for hepatocellular carcinoma. Liver
                   Transpl 2007;13:S48-54.
               12.  Kaido T, Mori A, Ogura Y, Hata K, Yoshizawa A, Iida T, Yagi S, Uemoto S. Living donor liver transplantation for recurrent
                   hepatocellular carcinoma after liver resection. Surgery 2012;151:55-60.
               13.  Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis
                   2007;25:310-2.
               14.  Shirabe K, Taketomi A, Morita K, Soejima Y, Uchiyama H, Kayashima H, Ninomiya M, Toshima T, Maehara Y. Comparative
                   evaluation of expanded criteria for patients with hepatocellular carcinoma beyond the Milan criteria undergoing living-related donor
   20   21   22   23   24   25   26   27   28   29   30